Incyte Corp
NASDAQ:INCY

Watchlist Manager

Incyte Corp

NASDAQ:INCY

Watchlist

Dividends

Price: 68.325 USD -0.72%

Market Cap: 13.2B USD

Have any thoughts about
Incyte Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 68.325 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

INCY Alert

Incyte Corp

68.325

-0.495 (-0.72%)

52 Week Range	51.18 83.38
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Incyte Corp

What unique competitive advantages
does Incyte Corp hold over its rivals?

What risks and challenges
does Incyte Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Incyte Corp.

What unique competitive advantages
does Incyte Corp hold over its rivals?

What risks and challenges
does Incyte Corp face in the near future?

Has there been any significant insider trading activity
in Incyte Corp recently?

Summarize the latest earnings call
of Incyte Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Incyte Corp.

Provide P/S
for Incyte Corp.

Provide P/E
for Incyte Corp.

Provide P/OCF
for Incyte Corp.

Provide P/FCFE
for Incyte Corp.

Provide P/B
for Incyte Corp.

Provide EV/S
for Incyte Corp.

Provide EV/GP
for Incyte Corp.

Provide EV/EBITDA
for Incyte Corp.

Provide EV/EBIT
for Incyte Corp.

Provide EV/OCF
for Incyte Corp.

Provide EV/FCFF
for Incyte Corp.

Provide EV/IC
for Incyte Corp.

Show me price targets
for Incyte Corp made by professional analysts.

What are the Revenue projections
for Incyte Corp?

How accurate were the past Revenue estimates
for Incyte Corp?

What are the Net Income projections
for Incyte Corp?

How accurate were the past Net Income estimates
for Incyte Corp?

What are the EPS projections
for Incyte Corp?

How accurate were the past EPS estimates
for Incyte Corp?

What are the EBIT projections
for Incyte Corp?

How accurate were the past EBIT estimates
for Incyte Corp?

Compare the revenue forecasts
for Incyte Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Incyte Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Incyte Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Incyte Corp compared to its peers.

Compare the P/E ratios
of Incyte Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Incyte Corp with its peers.

Analyze the financial leverage
of Incyte Corp compared to its main competitors.

Show all profitability ratios
for Incyte Corp.

Provide ROE
for Incyte Corp.

Provide ROA
for Incyte Corp.

Provide ROIC
for Incyte Corp.

Provide ROCE
for Incyte Corp.

Provide Gross Margin
for Incyte Corp.

Provide Operating Margin
for Incyte Corp.

Provide Net Margin
for Incyte Corp.

Provide FCF Margin
for Incyte Corp.

Show all solvency ratios
for Incyte Corp.

Provide D/E Ratio
for Incyte Corp.

Provide D/A Ratio
for Incyte Corp.

Provide Interest Coverage Ratio
for Incyte Corp.

Provide Altman Z-Score Ratio
for Incyte Corp.

Provide Quick Ratio
for Incyte Corp.

Provide Current Ratio
for Incyte Corp.

Provide Cash Ratio
for Incyte Corp.

What is the historical Revenue growth
over the last 5 years for Incyte Corp?

What is the historical Net Income growth
over the last 5 years for Incyte Corp?

What is the current Free Cash Flow
of Incyte Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Incyte Corp.

P/E
Price to Earnings

405.5

Current

28.5

Median

22.1

Industry

Higher than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

405.5

Market Cap

13.3B USD

Net Income

32.5m USD

All Countries

Forward Multiples

			Market Cap	P/E
US		Incyte Corp NASDAQ:INCY	13.3B USD	405.5
FR		Pharnext SCA OTC:PNEXF	6T USD	-180 740.1
US		Abbvie Inc NYSE:ABBV	310.2B USD	61.1
US		Amgen Inc NASDAQ:AMGN	142B USD	33.5
US		Gilead Sciences Inc NASDAQ:GILD	115B USD	915.4
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	101.6B USD	-213.4
US	E	Epizyme Inc F:EPE	94.1B EUR	-472.7
AU		CSL Ltd ASX:CSL	134.4B AUD	31.8
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.5B USD	16.6
US	S	Seagen Inc F:SGT	39.3B EUR	-54.7
NL		argenx SE XBRU:ARGX	35.8B EUR	-134.7

				Earnings Growth	P/E to Growth
US		Incyte Corp NASDAQ:INCY	Average P/E: 244 405.5	155%	2.6
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -180 740.1	N/A	N/A
US		Abbvie Inc NYSE:ABBV	61.1	413%	0.1
US		Amgen Inc NASDAQ:AMGN	33.5	73%	0.5
US		Gilead Sciences Inc NASDAQ:GILD	915.4	77%	11.9
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -213.4	48%	N/A
US	E	Epizyme Inc F:EPE	Negative Multiple: -472.7	N/A	N/A
AU		CSL Ltd ASX:CSL	31.8	65%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.6	44%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -54.7	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -134.7	N/A	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

51.7

2-Years Forward

P/E

3-Years Forward

P/E

8.7

	Franklin Covey Co NYSE:FC	36.1 USD -0.85%
	Mohawk Industries Inc NYSE:MHK	118.07 USD -0.91%
	Ardmore Shipping Corp NYSE:ASC	11.5 USD 1.68%
	ASGN Inc NYSE:ASGN	83.9 USD 0.04%
	Skyworks Solutions Inc NASDAQ:SWKS	89.91 USD 1.31%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	143.9599 USD -0.35%
	Bank of America Corp NYSE:BAC	43.96 USD -0.48%
	Mastercard Inc NYSE:MA	525.53 USD -0.48%
	Salesforce Inc NYSE:CRM	338 USD -1.64%
	Abbvie Inc NYSE:ABBV	175.52 USD -0.03%
	Home Depot Inc NYSE:HD	388.45 USD -1.06%

	Arista Networks Inc NYSE:ANET	112.485 USD -0.29%
	Visa Inc NYSE:V	315.5975 USD -0.66%
	Texas Pacific Land Corp NYSE:TPL	1 140 USD 0.61%
	KLA Corp NASDAQ:KLAC	633 USD 0.58%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.65 USD 0.14%

	Salesforce Inc NYSE:CRM	338 USD -1.64%
	Accenture PLC NYSE:ACN	360.38 USD -1.63%
	ServiceNow Inc NYSE:NOW	1 085.69 USD -0.51%
	EOG Resources Inc NYSE:EOG	118.65 USD -0.33%
	Copart Inc NASDAQ:CPRT	57.92 USD -0.52%
	Applied Materials Inc NASDAQ:AMAT	166 USD 1.47%

Incyte Corp
NASDAQ:INCY

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Incyte Corp NASDAQ:INCY

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Incyte Corp
NASDAQ:INCY

P/E
Price to Earnings